AAAAAA

   
Results: 1-25 | 26-34 |
Results: 26-34/34
PHENYTOIN CAUSES A RAPID INCREASE IN 6-BETA-HYDROXYCORTISOL URINARY-EXCRETION IN HUMANS - A PUTATIVE MEASURE OF CYP3A INDUCTION
Authors: FLEISHAKER JC PEARSON LK PETERS GR
Citation: Jc. Fleishaker et al., PHENYTOIN CAUSES A RAPID INCREASE IN 6-BETA-HYDROXYCORTISOL URINARY-EXCRETION IN HUMANS - A PUTATIVE MEASURE OF CYP3A INDUCTION, Journal of pharmaceutical sciences, 84(3), 1995, pp. 292-294
MULTIPLE-DOSE TOLERABILITY AND PHARMACOKINETICS OF TIRILAZAD MESYLATEAT DOSES OF UP TO 10 MG KG/DAY ADMINISTERED OVER 5-10 DAYS IN HEALTHY-VOLUNTEERS/
Authors: FLEISHAKER JC HULST LK PETERS GR
Citation: Jc. Fleishaker et al., MULTIPLE-DOSE TOLERABILITY AND PHARMACOKINETICS OF TIRILAZAD MESYLATEAT DOSES OF UP TO 10 MG KG/DAY ADMINISTERED OVER 5-10 DAYS IN HEALTHY-VOLUNTEERS/, International journal of clinical pharmacology and therapeutics, 32(5), 1994, pp. 223-230
LACK OF PHARMACOKINETIC INTERACTION BETWEEN CIMETIDINE AND TIRILAZAD MESYLATE
Authors: FLEISHAKER JC HULST LK PETERS GR
Citation: Jc. Fleishaker et al., LACK OF PHARMACOKINETIC INTERACTION BETWEEN CIMETIDINE AND TIRILAZAD MESYLATE, Pharmaceutical research, 11(2), 1994, pp. 341-344
LACK OF A PHARMACOKINETIC PHARMACODYNAMIC INTERACTION BETWEEN NIMODIPINE AND TIRILAZAD MESYLATE IN HEALTHY-VOLUNTEERS/
Authors: FLEISHAKER JC HULST LK PETERS GR
Citation: Jc. Fleishaker et al., LACK OF A PHARMACOKINETIC PHARMACODYNAMIC INTERACTION BETWEEN NIMODIPINE AND TIRILAZAD MESYLATE IN HEALTHY-VOLUNTEERS/, Journal of clinical pharmacology, 34(8), 1994, pp. 837-841
SAFETY STUDY OF TIRILAZAD MESYLATE IN PATIENTS WITH ACUTE ISCHEMIC STROKE (STIPAS)
Authors: HALEY EC PUTMAN S ANDERSON F MORRISON MR TUTTLE P PASSINI BT WILNER AN ALLEN FH ADAMS R CARL B BUEKE C NICHOLS F HESS D HYDER S BURCH G FOLEY C BIVINS DH WILSON JT SISK MA NOLAN DB ELIAS WS SHEPPARD GL CROWE NF MASSEY S HURST D ZONTINE D GUSTIN KH MCCLURE K GRANNER M WOLF S GWYNN M METTETAL RW TORNER JC KONGABLE G WILKINSON S HANSEN CA WOLFF MC GIBSON RS BERGIN JD TRUSKOWSKI L LIGHTFOOT G LIGHTFOOT A POLIN A SOLENSKI NJ STITELER J PETERS GR BRYAN WJ
Citation: Ec. Haley et al., SAFETY STUDY OF TIRILAZAD MESYLATE IN PATIENTS WITH ACUTE ISCHEMIC STROKE (STIPAS), Stroke, 25(2), 1994, pp. 418-423
THE EFFECT OF PHENYTOIN ON THE PHARMACOKINETICS OF TIRILAZAD MESYLATEIN HEALTHY MALE-VOLUNTEERS
Authors: FLEISHAKER JC HULST LK PETERS GR
Citation: Jc. Fleishaker et al., THE EFFECT OF PHENYTOIN ON THE PHARMACOKINETICS OF TIRILAZAD MESYLATEIN HEALTHY MALE-VOLUNTEERS, Clinical pharmacology and therapeutics, 56(4), 1994, pp. 389-397
EFFECT OF AGE AND GENDER ON TIRILAZAD PHARMACOKINETICS IN HUMANS
Authors: HULST LK FLEISHAKER JC PETERS GR HARRY JD WRIGHT DM WARD P
Citation: Lk. Hulst et al., EFFECT OF AGE AND GENDER ON TIRILAZAD PHARMACOKINETICS IN HUMANS, Clinical pharmacology and therapeutics, 55(4), 1994, pp. 378-384
PLASMA EMISSION-SPECTROMETRY
Authors: BEAUCHEMIN D LEBLANC JCY PETERS GR PERSAUD AT
Citation: D. Beauchemin et al., PLASMA EMISSION-SPECTROMETRY, Analytical chemistry, 66(12), 1994, pp. 180000462-180000499
EFFECT OF PRE-EVAPORATING THE SOLVENT ON THE ANALYTICAL PERFORMANCE OF INDUCTIVELY-COUPLED PLASMA-MASS SPECTROMETRY
Authors: PETERS GR BEAUCHEMIN D
Citation: Gr. Peters et D. Beauchemin, EFFECT OF PRE-EVAPORATING THE SOLVENT ON THE ANALYTICAL PERFORMANCE OF INDUCTIVELY-COUPLED PLASMA-MASS SPECTROMETRY, Spectrochimica acta, Part B: Atomic spectroscopy, 48(12), 1993, pp. 1481-1494
Risultati: 1-25 | 26-34 |